LAB · Standard BioTools Inc
United States · RS rating 10 · As of 2026-10-14
| Price | 0.63 USD |
|---|---|
| 1-day change | -4.2% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 27 / 14 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 19 / 44 |
| Industry group (rank) | Medical-Systems/Equip (93) |
| EPS growth Q/Q | +155.6% |
| Sales growth Q/Q | +21.7% |
| Distance from 52-week high | +62.4% |
| Market cap (USD) | $348.7M |